Based on its mutation frequency and disease penetrance, PALB2 is considered as the third major high-risk breast cancer gene alongside BRCA1 and BRCA2 [1, 2], all of which being key factors for the maintenance of genome stability. This evidence concerns the gene BRCA2 and breast carcinoma.